Prot# CA180004: Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Advanced Breast Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date8/23/078/23/10

Funding

  • Bristol-Myers Squibb Company (CA180004)